[Development of immunotherapy against HER2/neu: hydrophobized polysaccharides/oncoprotein complexes and human dendritic cells].
Ikuta
Y
Y
2nd Department of Internal Medicine, Mie Univ. Sch. Med.
Wang
L
L
Shiku
H
H
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D010446:Peptide Fragments / Q000276:immunology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology*
D000951:Antigens, Neoplasm; D010446:Peptide Fragments; D018719:Erb-b2 Receptor Tyrosine Kinases; C091577:HER2-neu-derived peptide (654-662)